Taizhou Blazer Biomedical Technology Co., Ltd.is located in Taizhou, China, the hometown of pharmaceuticals industry, focusing on the development of APIs and key drug intermediates with high technical barriers, high difficulties and high added value, committed to the development and customerized synthesis of drug intermediates, clinical new drug intermediates and new drug technology. we have 400m2 small and pilot laboratories and cooperative plants with the production conditions and technical capacity from gram level to ton level.
The R & D and management team of the company has rich experience and profound knowledge in organic synthesis, chemical process, and pharmaceutical chemistry market operation, the company has strict quality control system to ensure high-speed, high-quality products and services to accelerate the progress of customer’s research, development and production, to reduce customer’s costs.
After four years of unremitting efforts, we become the leader of olivetol series and indazole series products in China, here, we are looking forward to sincere cooperation with customers from all over the world.
Year of Establishment:
2016
Total Assets(USD):
choose not to disclose
Total Number of Staff:
less than 10 person
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Other
R&D capacity:
Other
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Other Competitive Advantages:
Patents and Copyrights:
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
